AnteoTechAnteoTechAnteoTechAnteoTech
  • Home
  • About
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • ADVISORY BOARDS
  • Life Science
    • ANTEOBIND
      • ANTEOBIND PUBLICATIONS
    • PRODUCTS
    • CONTRACT SERVICES
    • CASE STUDIES
    • WEBINARS
  • Energy
    • WEBINARS
  • EuGeni
  • Newsroom
  • Investors
    • 2021 ANNUAL GENERAL MEETING
    • ASX ANNOUNCEMENTS
    • CORPORATE GOVERNANCE & COMPANY POLICY
    • VIEW ON ASX
  • Customer Login
  • Contact

Australian-made RATs await TGA approval amid rapid antigen test shortage

    Home In the News Australian-made RATs await TGA approval amid rapid antigen test shortage
    Previous

    Australian-made RATs await TGA approval amid rapid antigen test shortage

    By AnteoTech | In the News | 0 comment | 18 January, 2022 |

    Australian-made RATs await TGA approval amid rapid antigen test shortage

     

    No tags.

    AnteoTech

    More posts by AnteoTech

    Related Post

    • Exxe Appointed as Italian Distributor

      By AnteoTech | 0 comment

      AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech’s fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT). We are excited atRead more

    • Spanish and Portuguese Distribution Agreement for EuGeni

      By AnteoTech | 0 comment

      AnteoTech broadens European market exposure, securing a Spanish and Portuguese Distribution Agreement for EuGeni AnteoTech is pleased to welcome another newly appointed distributor to the EuGeni family. Most recently, AnteoTech has appointed Vitro Master DiagnosticaRead more

    • AnteoTech renews AnteoBind contract with Ellume

      By AnteoTech | 0 comment

      AnteoTech is pleased to advise that it has renewed its contract with leading healthcare diagnostic partner Ellume Ltd. (“Ellume”) for the supply of AnteoBind to be used in Ellume’s range of tests. Ellume is anRead more

    Previous

    Recent Posts

    • Australian-made RATs await TGA approval amid rapid antigen test shortage
    • AnteoTech renews AnteoBind contract with Ellume
    • Spanish and Portuguese Distribution Agreement for EuGeni
    • Exxe Appointed as Italian Distributor

    Recent Comments

      Quick Links

      • About
      • Life Science
      • Energy
      • Investors
      • Customer Login

      Investors

      • ASX Announcements
      • Corporate Governance & Company Policy
      • Financial Reporting
      • Share Price Information

      Contact Us

      If you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.

      For all investor-related queries please email investors@anteotech.com.

      Copyright © AnteoTech 2021. All rights reserved. AnteoCoat/AnteoBind are trademarks of the AnteoTech group of companies. All other trademarks referenced are owned by their respective companies.
      Website by Start Digital
      • Home
      • About
        • MANAGEMENT TEAM
        • BOARD OF DIRECTORS
        • ADVISORY BOARDS
      • Life Science
        • ANTEOBIND
          • ANTEOBIND PUBLICATIONS
        • PRODUCTS
        • CONTRACT SERVICES
        • CASE STUDIES
        • WEBINARS
      • Energy
        • WEBINARS
      • EuGeni
      • Newsroom
      • Investors
        • 2021 ANNUAL GENERAL MEETING
        • ASX ANNOUNCEMENTS
        • CORPORATE GOVERNANCE & COMPANY POLICY
        • VIEW ON ASX
      • Customer Login
      • Contact
      AnteoTech